SPECTRUM OF GERMLINE CANCER SUSCEPTIBILITY GENE MUTATIONS IN BREAST AND OVARIAN CANCER PATIENTS IN THE BLACK SEA REGION OF TURKEY: SINGLE CENTER EXPERIENCE

Authors : Şenol ÇİTLİ, Yelda DAĞCIOĞLU, Esra AYDIN, Kemal KURTÇU

Pages : 41-48

Doi:10.48176/esmj.2023.102

View : 11 | Download : 5

Publication Date : 2023-03-29

Article Type : Research Paper

Abstract :Introduction: Breast cancer consists huge amount of the cancerrelated death in population. Ovarian cancer is the second most frequent seen type of gynecological cancer and has the highest mortality among gynecological cancers since most cases are detected late. The current study intended to determine the prevalence of oncogene mutations, especially BRCA1 and BRCA2, in high-risk patients diagnosed with ovarian and breast cancer in the Black Sea region of our country. Material and method: Between August 2017 and January 2022, a total of 223 individuals who applied to our center and met the genetic test criteria were included in the study. Next-generation sequencing insert ignore into journalissuearticles values(NGS); was used to detect germ-line deleterious variants in genes included in the oncogenetic panel of patients insert ignore into journalissuearticles values(34 genes);. Results: Among the 223 patients analyzed within the scope of the study, 195 had breast cancer, and 28 had ovarian cancer, resulting in the detection of 15 different pathogenic variants of BRCA1 insert ignore into journalissuearticles values(%4,9); and BRCA2 insert ignore into journalissuearticles values(%6,7); genes in 26 insert ignore into journalissuearticles values(11.6%); patients. In the analysis of 32 oncogenes other than BRCA1 and BRCA2 genes, 26 different pathogenic insert ignore into journalissuearticles values(P); or likely pathogenic insert ignore into journalissuearticles values(LP); variants were detected in a total of 35 patients insert ignore into journalissuearticles values(15.7%);. Based on the analysis of 223 breast/ ovarian cancer patients together, 41 different pathogenic insert ignore into journalissuearticles values(P); or likely pathogenic insert ignore into journalissuearticles values(LP); variants were found in 61 patients insert ignore into journalissuearticles values(27.3%);. Furthermore, 65 different VUSs insert ignore into journalissuearticles values(Variant of Uncertain Significance); were detected in 73 patients insert ignore into journalissuearticles values(32.7%);. Conclusion: This is the first study to be conducted in our region in a single center located in the Black Sea region. The study was conducted in a single center within the Black Sea region and, to our knowledge, provides the first data in this region in terms of cancer genes other than BRCAs. To appreciate of the genetic susceptibility spectrum of hereditary breast and/or ovarian cancer better, it is imperative to clarify the risks associated with genes other than BRCAs, which carry a high risk for other breast and ovarian cancers, as well as BRCA1 and BRCA2. Therefore, patients in the risk group must undergo multigene panel testing in addition to routine BRCA1 and BRCA2 gene testing. We detected two novel variants in the BRCA2 gene and five novel variants other than BRCA oncogenes. Furthermore, the results of this study contributed to the development of our country\`s specific variant pool.
Keywords : ngs, brca1, chek2, Meme Over kanseri